We believe that the laser diodes should be optimized for your application - not vice versa!
Modulight's proven platform ML7710 is the most versatile and proven platform in the industry, used for many different cancer therapies. We are helping our customers in all phases from pre-clinical and clinical trials to approved PMAs.
Our 500+ years of engineering experience in designing & manufacturing diode lasers has made us a long-term strategic partner for many companies for the laser chip needs.
Lasers are used in ophthalmology for many indications, such as treating ocular tumors, glaucoma, and intraretinal vascular abnormalities.
Controlled and repeatable lighting is essential for in-vitro and in-vivo studies of photoreactive components. Modulight’s in-vitro and in-vivo product family supports all existing photosensitizers.
Modulight products in spotlight
ML7710 is truly the most versatile multichannel & multi-indication laser in the world. The treatment flow has been optimized and it can be further customized to specific needs. ML7710 supports all know photosensitizers. As the only true medical laser platform it also boasts unmatched security for the investment.
ML8500 is an automatic system for illuminating well plates. ML8500 has up to six built-in lasers. Cloud-based composing of illumination programs can be done remotely which enables effective research work. ML8500 keeps sample plates within specified temperature and CO2 range.
ML6600 is a small plug-and-play laser system with up to 3 lasers of different wavelengths built-in. ML6600 is designed for users that don’t have time or interest for all the complexity with drivers, cooling, power supplies, etc. Just unbox it, and take into use! When ordering, you may request 1–3 wavelengths from the wavelength range 400–2000 nm.
We are the laser expert in your team
We’re helping people with their novel ideas. We have experience in productization, manufacturing subassemblies in regular production, as well as working to support end-of-life as equally important phase in the life cycle of a medical product.
Modulight in social media
Trials involving 1,077 people showed the injection led to them making antibodies and T-cells that can fight coronavirus. https://t.co/8cYpOvdZDv
Meet Modulight team:
Subscribe to Modulight newsletter
We are sending out a newsletter to our friends and customers a few times per year. Stay informed about what is going on and subscribe! You can always as easily opt-out.